학술논문

Evaluating the impact of summer vacation on the visual acuity of AMD patients treated with ranibizumab.
Document Type
Journal Article
Source
Eye. Nov2015, Vol. 29 Issue 11, p1453-1457. 5p.
Subject
*VISUAL acuity
*LUCENTIS (Drug)
*OPTICAL coherence tomography
*OPHTHALMOLOGY
*SPECTRUM analysis
*LONGITUDINAL method
*NEOVASCULARIZATION inhibitors
*VASCULAR endothelial growth factor antagonists
*ANGIOGRAPHY
*COMPARATIVE studies
*DRUGS
*HOLIDAYS
*INJECTIONS
*RESEARCH methodology
*MEDICAL cooperation
*PATIENT compliance
*REOPERATION
*RESEARCH
*RETINAL degeneration
*EVALUATION research
*THERAPEUTICS
Language
ISSN
0950-222X
Abstract
Purpose: To evaluate the impact of traditional French summer vacation on visual acuity and spectral domain-optical coherence tomography (SD-OCT) of Wet AMD patients being treated with intravitreal Ranibizumab.Methods: This was a consecutive, comparative, single-centre, prospective analysis. All patients who were being treated with intravitreal injection of 0.5 mg ranibizumab at Cergy Pontoise Hospital, Department of Ophthalmology between July 2013 and September 2014 were included. Patients were divided into two groups: (A) patients who skipped one ranibizumab intravitreal injection during holidays, and (B) patients who received injection during their holidays. Evaluations occurred prior to traditional holiday (baseline) and 2 months later, consisting of BCVA using ETDRS, and a complete ophthalmic examination that included slit-lamp biomicroscopy, fundus examination, fluorescein angiography (FA), indocyanine green angiography (ICGA), and spectral domain-optical coherence tomography (SD-OCT). All patients were being treated with PRN anti-VEGF regimen and criteria for reinjection included a visual acuity loss >5 ETDRS letters and/or an increase of central retinal thickness, presence of subretinal fluid, intraretinal fluid, or pigment epithelium detachment. If reinjection criteria were not met, patients were advised to return in 4 weeks.Results: The mean visual acuity change was -0.071 ± 0.149 (LogMAR) in group A and + 0.003 ± 0.178 in group B (P = 0.041). At the second visit (2 months after preholidays visit), 61.8% of patients in group A had SRF and/or intraretinal cysts, and only 27.6% of patients in group B. There was a significant difference in the persistence of fluid between the two groups (P = 0.007, χ(2)-test).Conclusion: This cases series demonstrated the detrimental impact of holidays on visual acuity in patients treated with ranibizumab for AMD, which, in spite of their treatment regimen, still leave in vacation. Therefore, it is important to convey the message of treatment adherence to patients, despite their need of holidays. [ABSTRACT FROM AUTHOR]